Nkcfo LLC Invests $476,000 in Inotiv, Inc. (NASDAQ:NOTV)

Nkcfo LLC purchased a new position in shares of Inotiv, Inc. (NASDAQ:NOTV) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 115,000 shares of the company’s stock, valued at approximately $476,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Vantage Point Financial LLC purchased a new stake in shares of Inotiv during the fourth quarter worth $1,393,000. Thurston Springer Miller Herd & Titak Inc. grew its stake in Inotiv by 612.5% during the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 127,257 shares of the company’s stock valued at $527,000 after acquiring an additional 109,397 shares in the last quarter. Calamos Advisors LLC acquired a new stake in Inotiv in the 4th quarter valued at about $275,000. Geode Capital Management LLC boosted its holdings in shares of Inotiv by 7.7% during the 3rd quarter. Geode Capital Management LLC now owns 250,895 shares of the company’s stock worth $427,000 after purchasing an additional 18,039 shares during the last quarter. Finally, KPP Advisory Services LLC grew its position in shares of Inotiv by 15.8% in the fourth quarter. KPP Advisory Services LLC now owns 275,267 shares of the company’s stock valued at $1,140,000 after purchasing an additional 37,549 shares in the last quarter. 18.17% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Inotiv news, Director Nigel Brown purchased 7,500 shares of the stock in a transaction dated Tuesday, December 10th. The stock was acquired at an average cost of $4.26 per share, for a total transaction of $31,950.00. Following the acquisition, the director now owns 65,537 shares in the company, valued at $279,187.62. This trade represents a 12.92 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Robert Jr. Leasure sold 22,700 shares of the business’s stock in a transaction dated Friday, January 31st. The shares were sold at an average price of $4.15, for a total transaction of $94,205.00. Following the completion of the sale, the chief executive officer now owns 1,030,209 shares in the company, valued at approximately $4,275,367.35. This trade represents a 2.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders bought 71,029 shares of company stock valued at $314,248 and sold 26,872 shares valued at $112,854. Corporate insiders own 7.80% of the company’s stock.

Inotiv Stock Performance

Shares of Inotiv stock opened at $3.78 on Friday. The business’s 50 day moving average price is $4.42 and its 200 day moving average price is $2.89. The company has a market cap of $98.32 million, a price-to-earnings ratio of -0.82 and a beta of 3.58. The company has a debt-to-equity ratio of 2.29, a quick ratio of 1.22 and a current ratio of 1.37. Inotiv, Inc. has a one year low of $1.23 and a one year high of $11.42.

Inotiv (NASDAQ:NOTV) last announced its quarterly earnings results on Wednesday, February 5th. The company reported ($0.42) earnings per share for the quarter, missing the consensus estimate of ($0.32) by ($0.10). Inotiv had a negative net margin of 25.40% and a negative return on equity of 15.07%. On average, research analysts predict that Inotiv, Inc. will post -0.73 EPS for the current year.

Inotiv Profile

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.